BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38901674)

  • 1. Expression of L1 Cell Adhesion Molecule (L1CAM), A Nephronal Principal Cell Marker, in Nephrogenic Adenoma.
    Mannan R; Wang X; Mahapatra S; Wang S; Chinnaiyan AK; Skala SL; Zhang Y; McMurray LM; Zelenka-Wang S; Cao X; Sangoi AR; Dadhania V; Picken MM; Menon S; Ahmadie HA; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Mod Pathol; 2024 Jun; ():100540. PubMed ID: 38901674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
    Sharifai N; Abro B; Chen JF; Zhao M; He H; Cao D
    Hum Pathol; 2020 Aug; 102():23-32. PubMed ID: 32561332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
    Xiao GQ; Burstein DE; Miller LK; Unger PD
    Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
    Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
    Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.
    Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY
    Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
    Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
    Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
    Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and Morphology.
    Li L; Williamson SR; Castillo RP; Delma KS; Gonzalgo ML; Epstein JI; Kryvenko ON
    Am J Surg Pathol; 2023 Jan; 47(1):37-46. PubMed ID: 36395466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
    Wang XM; Mannan R; Zhang Y; Chinnaiyan A; Rangaswamy R; Chugh S; Su F; Cao X; Wang R; Skala SL; Hafez KS; Vaishampayan U; Mckenney J; Picken MM; Gupta S; Alaghehbandan R; Tretiakova M; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2024 Feb; 48(2):163-173. PubMed ID: 37994665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.
    Legesse T; Matoso A; Epstein JI
    Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas.
    Beeter MC; Fazili T; Yeh YA
    Cureus; 2023 Mar; 15(3):e35998. PubMed ID: 37041930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SATB2 as a Marker of the Proximal Nephron: Expression in Nephrogenic Adenoma and Correlation With Other Renal Tubular Markers.
    Ortiz-Rey JA; Álvarez-Sarria M; Conde-Ferreirós M; Morellón-Baquera R; Bellas-Pereira A; Baltazar ST; García-Acuña S; San-Miguel Fraile P; Suárez-Peñaranda JM; Fernández-Baltar C; Vieytes-Molares M; Domínguez-Arístegui P; Gómez-de María C; Fachal-Bermúdez C; González-Carreró J
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):145-153. PubMed ID: 36744623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma.
    Gupta A; Wang HL; Policarpio-Nicolas ML; Tretiakova MS; Papavero V; Pins MR; Jiang Z; Humphrey PA; Cheng L; Yang XJ
    Am J Surg Pathol; 2004 Sep; 28(9):1224-9. PubMed ID: 15316323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic adenoma of the urinary tract: A 6-year single center experience.
    Turcan D; Acikalin MF; Yilmaz E; Canaz F; Arik D
    Pathol Res Pract; 2017 Jul; 213(7):831-835. PubMed ID: 28554748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma.
    Allan CH; Epstein JI
    Am J Surg Pathol; 2001 Jun; 25(6):802-8. PubMed ID: 11395559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX2: a reliable marker for nephrogenic adenoma.
    Tong GX; Melamed J; Mansukhani M; Memeo L; Hernandez O; Deng FM; Chiriboga L; Waisman J
    Mod Pathol; 2006 Mar; 19(3):356-63. PubMed ID: 16400326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
    Hansel DE; Nadasdy T; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry in diagnostic surgical pathology of the prostate.
    Hameed O; Humphrey PA
    Semin Diagn Pathol; 2005 Feb; 22(1):88-104. PubMed ID: 16512601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
    Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.